13F HOLDINGS REPORT
BML Capital Management, LLC
Quarter ended Q2 2023 · Filed April 14, 2023 · Accession 0001754960-23-000107
Total Value
$115.7M
Positions
31
Other Managers
0
Confidential Omitted
No
Holdings (31)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78468R663 | 200,000 | $18.4M | 15.87% |
| 2 | ISHARES TR | 46436E718 | 125,000 | $12.6M | 10.87% |
| 3 | TILLYS INC | 886885102 | 1,154,844 | $8.9M | 7.70% |
| 4 | ABERCROMBIE & FITCH CO | ANF | 295,778 | $8.2M | 7.09% |
| 5 | CYTEIR THERAPEUTICS INC | 23284P103 | 3,146,296 | $5.7M | 4.95% |
| 6 | PARDES BIOSCIENCES INC | 69945Q105 | 3,986,577 | $5.3M | 4.55% |
| 7 | ADVERUM BIOTECHNOLOGIES INC | 00773U108 | 7,067,179 | $5.1M | 4.38% |
| 8 | ELIEM THERAPEUTICS INC | CLYM | 1,658,170 | $4.8M | 4.16% |
| 9 | ATHIRA PHARMA INC | 04746L104 | 1,864,907 | $4.7M | 4.03% |
| 10 | ENLIVEN THERAPEUTICS INC | ELVN | 212,179 | $4.6M | 4.02% |
| 11 | SATSUMA PHARMACEUTICALS INC | 80405P107 | 6,440,000 | $4.5M | 3.89% |
| 12 | DISC MEDICINE INC | IRON | 208,161 | $4.4M | 3.81% |
| 13 | TALARIS THERAPEUTICS INC | 87410C104 | 1,929,484 | $3.6M | 3.14% |
| 14 | EMBARK TECHNOLOGY INC | 29079J202 | 1,285,390 | $3.6M | 3.12% |
| 15 | METACRINE INC | 59101E103 | 6,167,458 | $3.5M | 3.04% |
| 16 | ORAMED PHARMACEUTICALS INC | ORMP | 1,355,925 | $3.0M | 2.56% |
| 17 | ASTROTECH CORP | ASTC | 220,410 | $2.3M | 2.03% |
| 18 | JOUNCE THERAPEUTICS INC | 481116101 | 1,087,961 | $2.0M | 1.74% |
| 19 | FORTE BIOSCIENCES INC | FBRX | 1,735,075 | $1.8M | 1.51% |
| 20 | ARCA BIOPHARMA INC | 00211Y506 | 706,930 | $1.4M | 1.22% |
| 21 | CARISMA THERAPEUTICS INC | CARM | 411,398 | $1.3M | 1.10% |
| 22 | RETRACTABLE TECHNOLOGIES INC | RVP | 668,575 | $1.2M | 1.01% |
| 23 | VERRICA PHARMACEUTICALS INC | VRCA | 150,000 | $975,000 | 0.84% |
| 24 | SURROZEN INC | SRZNW | 1,494,037 | $899,410 | 0.78% |
| 25 | MILESTONE PHARMACEUTICALS IN | MIST | 220,000 | $866,800 | 0.75% |
| 26 | LISATA THERAPEUTICS INC | LSTA | 243,839 | $791,258 | 0.68% |
| 27 | NEXTCURE INC | NXTC | 306,465 | $453,568 | 0.39% |
| 28 | GRAPHITE BIO INC | 38870X104 | 152,291 | $373,113 | 0.32% |
| 29 | PASSAGE BIO INC | PASG | 337,467 | $323,192 | 0.28% |
| 30 | ADICET BIO INC | ACET | 30,000 | $172,800 | 0.15% |
| 31 | NEOLEUKIN THERAPEUTICS INC | 64049K104 | 23,749 | $16,624 | 0.01% |